Arch Therapeutics, Inc.
ARTH
$0.20
$0.042627.07%
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -91.18% | -49.54% | -42.32% | -32.36% | -24.49% |
| Total Depreciation and Amortization | 9.09% | -14.81% | -32.26% | -34.38% | -31.25% |
| Total Amortization of Deferred Charges | 50.56% | 152.77% | 338.51% | 665.20% | -- |
| Total Other Non-Cash Items | 578.83% | 112.98% | -228.39% | -260.02% | -265.26% |
| Change in Net Operating Assets | 11.32% | -2.77% | 88.89% | 187.41% | 53.16% |
| Cash from Operations | 3.03% | -5.53% | 8.68% | 24.28% | 11.22% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -57.53% | -51.82% | -37.14% | -67.30% | 630.89% |
| Total Debt Repaid | 2.40% | -8.62% | -63.88% | -229.63% | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -5.18% | 6.33% | 32.85% | -2.79% | 569.29% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -279.37% | 87.55% | 118.12% | 65.51% | 100.85% |